Assessment of Knowledge and Willingness to Pay for HPV Vaccine among Women of Known HIV Status in Oyo State


  • Babalola Mojibola Arinola Lead City University, Department of Public Health
  • Folahanmi Tomiwa Akinsolu Lead City University, Ibadan, Nigeria
  • Oluwadare Marcus Obafemi Awolowo University
  • Olaniyan Adebisi Omolara Obafemi Awolowo University. Medical and Health Service, Ile-Ife. Osun- State
  • Omotayo Emmanuel Olanipekun University of Abuja FCT
  • Mohammed Olatunji Bello Project Coordinator, Albarka Health Spring Foundation Nigeria
  • Olasunkanmi Ridwan. A University of Ibadan, Faculty of Public Health



Knowledge, willingness to pay, HPV vaccine, women of known HIV status


This research examined the awareness and financial readiness of women with confirmed HIV status in Oyo State regarding the HPV vaccine. The findings revealed that the inclination to invest in HPV vaccines was limited among women with known HIV status in the surveyed region. The study employed the Health Promotion Model as its framework. A descriptive cross-sectional research approach was employed, involving a multi-stage sampling method to choose 397 women who were living with HIV within the study area. Data collection was carried out through the utilization of a pretested self-structured questionnaire. The gathered data was subsequently coded and entered into SPSS version 23.0 for analysis. The analysis encompassed both descriptive and inferential statistical techniques, with significance levels set at p≤0.05.

Mean age of the respondents was 44.18 ± 9.54 years, and 45.1% had secondary education as their highest educational qualifications. Also, 15.9% and 53.4% had good knowledge of HPV and cervical cancer respectively. About 17.1% had good knowledge of HPV vaccine; while 16.1% were willing to pay for HPV vaccine. In addition to this, 58.9% were willing to get their daughters vaccinated. More so, 55.4% acknowledged that they would be willing to pay for their daughter’s vaccine. Hypothetically, educational status was significantly associated with women’s knowledge of HPV (p<0.05). Furthermore, age and marital status were significantly associated with women’s knowledge of cervical cancer (p<0.05).

Based on the findings of the study, it is clear that women's awareness of HPV, cervical cancer, and the HPV vaccine was lacking. Additionally, only a small proportion of women expressed a willingness to cover the cost of the HPV vaccine, and just slightly more than half were open to having their daughters vaccinated. Consequently, there is an imperative to enhance women's understanding and furnish women with confirmed HIV status with comprehensive medical education about HPV, as it plays a crucial role in preventing cervical cancer.


Download data is not yet available.


Abba Kabir, Mwajim Bukar, Haruna Asura Nggada, Harun Bakari Rann, Abubakar Gidado, Alhaji Bukar Musa. Prevalence of human papillomavirus genotypes in cervical cancer in Maiduguri, Nigeria.Pan African Medical Journal. 2019;33:284. [doi: 10.11604/ pamj.2019.33.284.18338]

Agida TE, Akaba GO, Isah AY, Ekele B. Knowledge and perception of human papilloma virus vaccine among the antenatal women in a Nigerian tertiary hospital. Niger Med J. 2015;56:23–7

Ajenifuja, O.K., Ikeri, N.Z., Adeteye, O.V., & Banjo, A.A. (2018). Comparison between self sampling and provider collected samples for Human Papillomavirus (HPV) Deoxyribonucleic acid (DNA) testing in a Nigerian facility. Pan African Medical Journal. 2018;30:110. doi:10.11604/pamj.2018.30.110.14321

Akarolo-Anthony SN, Famooto AO, Dareng EO, Olaniyan OB, Offiong R, Wheeler CM, Adebamowo CA. Age-specific prevalence of human papilloma virus infection among Nigerian women. BMC Public Health. 2014;14(1):656.

Allen-Leigh, B., Rivera-Rivera, L., Yunes-Díaz, E., Portillo-Romero, A.J., Brown, B., León-Maldonado, L., Vargas-Guadarramag, G., Salmerón, J., & Lazcano-Ponce, E.C. (2020). Uptake of the HPV vaccine among people with and without HIV, cisgender and transgender women and men who have sex with men and with women at two sexual health clinics in Mexico City. Human vaccines & immunotherapeutics 2020, VOL. 16, NO. 4, 981–990

Bisi-Onyemaechi, A. I., Chikani, U. N., & Nduagubam, O. (2018).Reducing incidence of cervical cancer: knowledge and attitudes of caregivers in Nigerian city to human papilloma virus vaccination. Infectious agents and cancer, 13, 29.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, de Sanjose S, Castellsague X. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016;4(7):e453 –63.




How to Cite

Arinola, B. M. ., Akinsolu, F. T. ., Marcus, O. ., Omolara, O. A. ., Olanipekun, O. E. ., Bello, M. O. ., & Ridwan. A , O. . (2023). Assessment of Knowledge and Willingness to Pay for HPV Vaccine among Women of Known HIV Status in Oyo State. INTERNATIONAL JOURNAL OF HEALTH SYSTEMS AND MEDICAL SCIENCES, 2(11), 11–30.




Most read articles by the same author(s)